137 related articles for article (PubMed ID: 5733721)
1. [The content of Vi-antibodies and 7S Vi-antibodies in the serum of typhoid patients treated with Vi-antigen and levomycetin].
Sukhoroslova LI; Andreeva NP
Zh Mikrobiol Epidemiol Immunobiol; 1968 May; 45(5):83-7. PubMed ID: 5733721
[No Abstract] [Full Text] [Related]
2. [Use of the hemagglutination test for detecting Vi-antibodies in the sera of patients with typhoid fever and chronic carrier state during treatment with levomycetin].
Anan'ina NA
Zh Mikrobiol Epidemiol Immunobiol; 1966 Oct; 43(10):146. PubMed ID: 6003869
[No Abstract] [Full Text] [Related]
3. [VI-antibody formation in typhoid patients treated with VI-antigen, pentoxyl and levomycetin].
Kuliev MM
Zh Mikrobiol Epidemiol Immunobiol; 1968 Dec; 45(12):55-9. PubMed ID: 5733863
[No Abstract] [Full Text] [Related]
4. [The dynamics of 0-antibodies of various physico-chemical properties in typhoid fever treated with levomycetin and VI-antigen].
Sukhoroslova LI
Zh Mikrobiol Epidemiol Immunobiol; 1968; 45(10):111-4. PubMed ID: 5731554
[No Abstract] [Full Text] [Related]
5. Vi serology in screening of typhoid carriers: improved specificity by detection of Vi antibodies by counterimmunoelectrophoresis.
Chau PY; Tsang RS
J Hyg (Lond); 1982 Oct; 89(2):261-7. PubMed ID: 7130702
[TBL] [Abstract][Full Text] [Related]
6. [Changes in serum bactericidal properties in patients with typhoid fever and chronic carrier state treated with levomycetin].
Anan'ina NA
Zh Mikrobiol Epidemiol Immunobiol; 1966 Oct; 43(10):98-101. PubMed ID: 4976155
[No Abstract] [Full Text] [Related]
7. [A study of the avidity of Vi antibodies in typhoid fever patients and chronic carriers].
Bunin KV; Firsanov VI; Kravtsov EG; Sukhoroslova LI; Kapuka LP
Zh Mikrobiol Epidemiol Immunobiol; 1976 Oct; (10):65-9. PubMed ID: 1007716
[TBL] [Abstract][Full Text] [Related]
8. [Immunologic shifts in typhoid patients following immuno-antibiotic therapy with levomycetin and VI-antigen according to the results of the passive VI-hemagglutination test].
Shneĭder VP
Zh Mikrobiol Epidemiol Immunobiol; 1966 Jun; 43(6):26-32. PubMed ID: 6004905
[No Abstract] [Full Text] [Related]
9. [Long-term observations for Vi-antibody formation in patients following typhoid fever, treated with Vi-antigen in combination with levomycetin].
Shneĭder VP
Zh Mikrobiol Epidemiol Immunobiol; 1967 Sep; 44(9):146. PubMed ID: 5615960
[No Abstract] [Full Text] [Related]
10. [Clinical-epidemiological parallels in patients suffering from typhoid and paratyphoid fever treated with levomycetin in combination with vaccine].
Musabaev IK; Nevskiĭ MV; Ambartsumov SM; Mikhaĭlovskaia OG; Kotiuminskaia NA; David'ian AO
Sov Med; 1966 Jun; 29(6):64-9. PubMed ID: 4965445
[No Abstract] [Full Text] [Related]
11. Influences of trimethoprim-sulphamethoxazole and chloramphenicol on immunoglobulin and antibody response in typhoid fever.
Hsieh WC; Hsieh BS
Southeast Asian J Trop Med Public Health; 1974 Mar; 5(1):17-21. PubMed ID: 4839076
[No Abstract] [Full Text] [Related]
12. [Treatment of typhoid fever patients with high doses of Vi-antigen in association with levomycetin].
Bunin KV; Sukhoroslova LI
Sov Med; 1968 Sep; 31(9):17-22. PubMed ID: 5747026
[No Abstract] [Full Text] [Related]
13. [Prevention of bacterial carrier state in typhoid and paratyphoid patients by means of antibiotic-vaccineotherapy. II. The dynamics of immunologic indices in typhoid and paratyphoid patients treated with levomycetin and dry alcoholic typho-paratyphoid B divaccine].
Tendetnik IuIa; Kilesso VA; Vydrina EI; Leĭtman MZ; Taratorina OM
Zh Mikrobiol Epidemiol Immunobiol; 1966 Apr; 43(4):73-80. PubMed ID: 4978572
[No Abstract] [Full Text] [Related]
14. [The dynamics of Vi-antibodies of different classes in typhoid patients during their treatment with levomycetin combined with alcoholic monovaccine and Vi-antigen].
Sukhoroslova LI; Deriagin IuP
Zh Mikrobiol Epidemiol Immunobiol; 1973 Oct; 50(10):15-8. PubMed ID: 4787689
[No Abstract] [Full Text] [Related]
15. [Anti-typhoid vaccine prophylaxis and vaccine therapy in carrier states and in typhoid fever. I. Convalescent carriers].
Buşilă VT; Vasilescu I; Vâlceanu M; Fitărău A; Pintea L
Microbiol Parazitol Epidemiol (Bucur); 1970; 15(4):305-11. PubMed ID: 5456200
[No Abstract] [Full Text] [Related]
16. [Recurrent typhoid in patients treated with levomycetin].
Shneĭder VP
Klin Med (Mosk); 1966 Dec; 44(12):124-8. PubMed ID: 6004337
[No Abstract] [Full Text] [Related]
17. [Determination of 7S typhoid antibodies in the diagnosis of carrier state].
Liuksemburg KI; Chernokhvostova EV; Rozentalene LV; Beliaeva AI
Zh Mikrobiol Epidemiol Immunobiol; 1966 Jun; 43(6):18-23. PubMed ID: 6004903
[No Abstract] [Full Text] [Related]
18. [Clinical evaluation of the passive hemagglutination test in typhoid fever].
Kossakiewicz-Sulkońska B
Przegl Epidemiol; 1970; 24(4):483-9. PubMed ID: 5495312
[No Abstract] [Full Text] [Related]
19. Differential agglutination of particulate Vi and O antigens by the IgM and IgG class antibodies.
Chau PY; Ng MH
Aust J Exp Biol Med Sci; 1978 Feb; 56(1):39-45. PubMed ID: 666676
[TBL] [Abstract][Full Text] [Related]
20. [Comparative evaluation of diagnostic titers of incomplete O- and Vi-antibodies belonging to different immunoglobulin classes in typhoid fever and chronic bacterial carrier state].
Bunin KV; Suleĭmanov AK
Zh Mikrobiol Epidemiol Immunobiol; 1979 Sep; (9):96-7. PubMed ID: 494903
[No Abstract] [Full Text] [Related]
[Next] [New Search]
